178 (PB166): Patient-derived models of ER+ HER2 - metastatic breast cancers reveal KRAS-MAPK signalling pathway as therapeutic target for overcoming resistance to trastuzumab-deruxtecan
Marangoni, E., El-Botty, L., Montaudon, E., Darrien, H., Dahmani, A., Sourd, L., Champenois, G., Nicolas, A., Dutertre, G., Vincent-Salomon, A., Courtois, L., Planchon, J. Masliah, Bièche, I., Coussy, F., Cabel, L.
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
Abstract 5782: Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Decaudin, Didier, Botty, Rania EL, Diallo, Béré, Massonnet, Gerald, Fleury, Justine, Naguez, Adnan, Dubois, Marine, Davies, Emma J., Smith, Aaron, Wilson, Joanne, Howes, Colin, Smith, Paul, Cassoux, Nathalie, Mariani, Pascale, Piperno-Neumann, Sophie, Roman, Sergio Roman, Nemati, Fariba
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article